From October 28, 2021 to February 10, 2022, the company has repurchased 883,300 shares, representing 1.13% for ¥7,999.54 million. With this, the company has completed the repurchase of 883,300 shares, representing 1.13% for ¥7,999.54 million under the buyback announced on October 28, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,736 JPY | +0.63% | +6.18% | -15.52% |
Mar. 31 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
Mar. 30 | Kobayashi factory searched over deaths possibly linked to supplements | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.52% | 2.73B | |
+14.44% | 393B | |
+12.63% | 142B | |
+18.72% | 77.56B | |
-12.03% | 65.38B | |
-3.11% | 43.08B | |
+6.12% | 35.13B | |
+10.76% | 18.14B | |
+15.17% | 15.83B | |
-2.72% | 11.59B |
- Stock Market
- Equities
- 4967 Stock
- News Kobayashi Pharmaceutical Co., Ltd.
- Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 28, 2021.